Related Experiment Videos
Enkephalin analogues containing beta-naphthylalanine at the fourth position
D F Mierke1, O E Said-Nejad, P W Schiller
1Department of Chemistry, University of California, San Diego, La Jolla 92093.
Biopolymers
|January 1, 1990
Summary
Enkephalin analogues with beta-naphthylalanine show increased opiate activity. Conformational analysis reveals structural requirements for mu-receptor selectivity, favoring extended structures.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Peptide Science
Background:
- Enkephalins are endogenous opioid peptides crucial for pain modulation.
- Understanding structure-activity relationships is key to developing novel analgesics.
- Aromatic side chains significantly influence opiate receptor binding and activity.
Purpose of the Study:
- To investigate the role of aromatic side chains in enkephalin analogues on opiate receptor activity.
- To synthesize and analyze novel enkephalin analogues with beta-naphthylalanine substitutions.
- To elucidate conformational requirements for mu- and delta-opioid receptor selectivity.
Main Methods:
- Synthesis of linear and cyclic enkephalin analogues incorporating beta-naphthylalanine.
- Biological activity assays at mu- and delta-opiate receptors.
- Conformational analysis using techniques to assess side chain positioning and hydrogen bonding.
Main Results:
- Enkephalin analogues with beta-naphthylalanine exhibited enhanced activity at the mu-opiate receptor.
- Cyclic analogues provided insights into the necessity of L-chirality for the aromatic residue at position 4.
- Conformational analysis indicated an extended structure with distant aromatic rings for mu-selectivity.
Conclusions:
- The aromatic side chain at position 4 of enkephalin is critical for modulating opiate activity.
- Specific conformations, characterized by extended structures, are required for high mu-opioid receptor selectivity.
- Findings support a model differentiating structural requirements for mu and delta receptor binding.